Long-term outcomes of pediatric liver transplantation using organ donation after circulatory death: Comparison between full and reduced grafts

Pediatr Transplant. 2022 Dec;26(8):e14385. doi: 10.1111/petr.14385. Epub 2022 Sep 10.

Abstract

Background: The shortage of donors' livers for pediatric recipients inspired the search for alternatives including donation after cardiac death (DCD).

Methods: Retrospective review of pediatric liver transplant (PLT) using DCD grafts. Patients were divided into either FLG or RLG recipients. Pre-transplant recipient parameters, donor parameters, operative parameters, post-transplant recipient parameters, and outcomes were compared.

Results: Overall, 14 PLTs from DCD donors between 2005 and 2018 were identified; 9 FLG and 5 RLG. All donors were Maastricht category III. Cold ischemia time was significantly longer in RLG (8.2 h vs. 6.2 h; p = .038). Recipients of FLG were significantly older (180 months vs. 7 months; p = .012) and waited significantly longer (168 days vs. 22 days; p = .012). Recipients of RLG tended to be sicker in the immediate pre-transplant period and this was reflected by the need for respiratory or renal support. There was no significant difference between groups regarding long-term complications. Three patients in each group survived more than 5 year post-transplant. One child was re-transplanted in the RLG due to portal vein thrombosis but failed to survive after re-transplant. One child from FLG also died from a non-graft-related cause.

Conclusions: Selected DCD grafts are an untapped source to widen the donor pool, especially for sick recipients. In absence of agreed criteria, graft and recipient selection for DCD grafts should be undertaken with caution.

Keywords: complications; donation after cardiac death; full graft; pediatric liver transplantation; reduced graft; survival.

MeSH terms

  • Brain Death
  • Child
  • Death
  • Graft Survival
  • Humans
  • Liver Transplantation* / adverse effects
  • Retrospective Studies
  • Tissue Donors
  • Tissue and Organ Procurement*